基因ID | taxid | GeneDate LocusTag | Symbol Synonyms | Symbolfna Fullnamefna | dbXrefs | chromosome maplocation | description | genetype fnastatus | Otherdesignations | Featuretype |
100036065 | 10090 | 20170408 | Elsgp2 | Elsgp2 elevated serum gp70 2 | MGI:MGI:3040462 | 13 | elevated serum gp70 2 | unknown O | ||
100036066 | 10090 | 20200922 | Lwq20 Lvrq7 | Lwq20 liver weight QTL 20 | MGI:MGI:3042917 | 11 | liver weight QTL 20 | unknown O | liver weight QTL 7 | |
100036067 | 10090 | 20170408 | Epfq3 | Epfq3 epididymal fat pad weight QTL 3 | MGI:MGI:3042928 | 17 | epididymal fat pad weight QTL 3 | unknown O | ||
100036068 | 10090 | 20170408 | Vtbt13 | Vtbt13 vertebral trabecular bone trait 13 | MGI:MGI:3045055 | 12 12 28.94 cM | vertebral trabecular bone trait 13 | unknown O | ||
100036069 | 10090 | 20170408 | Gbrln | Gbrln granular brain lesions | MGI:MGI:3047352 | 7 7 33.88 cM | granular brain lesions | unknown O | ||
100036070 | 10090 | 20211016 | Hipp5 DGVi11a | Hipp5 hippocampal weight 5 | MGI:MGI:3052079 | 11 11 10.44 cM | hippocampal weight 5 | unknown O | ||
100036071 | 10090 | 20170408 | Nrtim2 | Nrtim2 neurotensin immunoreactivity 2 | MGI:MGI:3053624 | 13 | neurotensin immunoreactivity 2 | unknown O | ||
100036072 | 10090 | 20170408 | Mp53d2 | Mp53d2 modifier of p53-deficiency 2 | MGI:MGI:3054217 | 19 19 35.97 cM | modifier of p53-deficiency 2 | unknown O | ||
100036074 | 10090 | 20170408 | Skmw9 | Skmw9 skeletal muscle weight 9 | MGI:MGI:3510243 | 2 | skeletal muscle weight 9 | unknown O | ||
100036075 | 10090 | 20170408 | Grwtj4 | Grwtj4 growth trajectory 4 | MGI:MGI:3510722 | 15 | growth trajectory 4 | unknown O | ||
100036076 | 10090 | 20170408 | Fmgty2 | Fmgty2 femur geometry 2 | MGI:MGI:3512799 | 3 3 4.85 cM | femur geometry 2 | unknown O | ||
100036077 | 10090 | 20170408 | Fmgty6 | Fmgty6 femur geometry 6 | MGI:MGI:3512919 | 7 7 33.88 cM | femur geometry 6 | unknown O | ||
100036078 | 10090 | 20170408 | Hlpx | Hlpx heterogeneity in eye lens protein photooxidation kinetics | MGI:MGI:3521873 | 8 8 74.46 cM | heterogeneity in eye lens protein photooxidation kinetics | unknown O | ||
100036079 | 10090 | 20170408 | Arigg5 | Arigg5 anti-RBC IgG antibodies 5 | MGI:MGI:3524760 | 4 | anti-RBC IgG antibodies 5 | unknown O | ||
100036080 | 10090 | 20170408 | Idd23 | Idd23 insulin dependent diabetes susceptibility 23 | MGI:MGI:3525329 | 17 | insulin dependent diabetes susceptibility 23 | unknown O | ||
100036081 | 10090 | 20170408 | W10q3 | W10q3 weight 10 weeks QTL 3 | MGI:MGI:3526923 | 3 | weight 10 weeks QTL 3 | unknown O | ||
100036082 | 10090 | 20170408 | W6q4 | W6q4 weight 6 weeks QTL 4 | MGI:MGI:3526936 | 6 | weight 6 weeks QTL 4 | unknown O | ||
100036083 | 10090 | 20170408 | Lgaq5 | Lgaq5 late growth adjusted QTL 5 | MGI:MGI:3527501 | 10 | late growth adjusted QTL 5 | unknown O | ||
100036084 | 10090 | 20170408 | Lgaq1 | Lgaq1 late growth adjusted QTL 1 | MGI:MGI:3527563 | 11 | late growth adjusted QTL 1 | unknown O | ||
100036085 | 10090 | 20170408 | Manln15 | Manln15 mandible length 15 | MGI:MGI:3528320 | 14 14 11.53 cM | mandible length 15 | unknown O | ||
100036086 | 10090 | 20170408 | Nba5 | Nba5 New Zealand Black autoimmunity 5 | MGI:MGI:3529863 | 7 | New Zealand Black autoimmunity 5 | unknown O | ||
100036087 | 10090 | 20170408 | Obwq2 | Obwq2 obesity and body weight QTL 2 | MGI:MGI:3531517 | 5 5 42.22 cM | obesity and body weight QTL 2 | unknown O | ||
100036088 | 10090 | 20170408 | Adip13 | Adip13 adiposity 13 | MGI:MGI:3531538 | 5 5 26.89 cM | adiposity 13 | unknown O | ||
100036089 | 10090 | 20170408 | Gct6 | Gct6 granulosa cell tumorigenesis 6 | MGI:MGI:3574516 | X | granulosa cell tumorigenesis 6 | unknown O | ||
100036090 | 10090 | 20170408 | Erars2 | Erars2 erosive arthritis susceptibility 2 | MGI:MGI:3577036 | 4 4 51.36 cM | erosive arthritis susceptibility 2 | unknown O | ||
100036091 | 10090 | 20170408 | Scpro11 | Scpro11 Stem cell proliferation 11 | MGI:MGI:3578831 | X X 57.4 cM | Stem cell proliferation 11 | unknown O | ||
100036092 | 10090 | 20170408 | Bntq14 | Bntq14 bone traits QTL 14 | MGI:MGI:3578895 | 13 | bone traits QTL 14 | unknown O | ||
100036093 | 10090 | 20170408 | Avptaq3 | Avptaq3 Avp transcript abundance QTL 3 | MGI:MGI:3580596 | 13 13 45.05 cM | Avp transcript abundance QTL 3 | unknown O | ||
100036094 | 10090 | 20170408 | Igan1 | Igan1 IgA nephropathy 1 | MGI:MGI:3581245 | 10 10 7.27 cM | IgA nephropathy 1 | unknown O | ||
100036095 | 10090 | 20170408 | Ptnu1 | Ptnu1 proteinuria 1 | MGI:MGI:3583624 | 8 8 22.16 cM | proteinuria 1 | unknown O | ||
100036096 | 10090 | 20170408 | Cplaq10 | Cplaq10 circadian period of locomotor activity 10 | MGI:MGI:3588345 | 12 12 15.9 cM | circadian period of locomotor activity 10 | unknown O | ||
100036097 | 10090 | 20170408 | Vacq5 | Vacq5 voluntary alcohol consumption QTL 5 | MGI:MGI:3590250 | 13 13 14.44 cM | voluntary alcohol consumption QTL 5 | unknown O | ||
100036098 | 10090 | 20170408 | Marq4 | Marq4 methamphetamine response QTL 4 | MGI:MGI:3590513 | 12 | methamphetamine response QTL 4 | unknown O | ||
100036099 | 10090 | 20170408 | Lmrq5 | Lmrq5 Leishmania major resistance QTL 5 | MGI:MGI:3603270 | 15 | Leishmania major resistance QTL 5 | unknown O | ||
100036100 | 10090 | 20170408 | Mfiq2 | Mfiq2 M16 feed intake QTL 2 | MGI:MGI:3604748 | 13 | M16 feed intake QTL 2 | unknown O | ||
100036101 | 10090 | 20170408 | Spnw2 | Spnw2 spleen weight 2 | MGI:MGI:3604984 | 3 | spleen weight 2 | unknown O | ||
100036102 | 10090 | 20170408 | Mtxe6 | Mtxe6 methotrextate efficacy 6 | MGI:MGI:3606293 | 14 | methotrextate efficacy 6 | unknown O | ||
100036103 | 10090 | 20211002 | Sdtq2 L2 | Sdtq2 skull development traits QTL 2 | MGI:MGI:3607512 | 2 | skull development traits QTL 2 | unknown O | ||
100036104 | 10090 | 20170408 | Mohg2 | Mohg2 modifier of hg 2 | MGI:MGI:3607562 | X | modifier of hg 2 | unknown O | ||
100036105 | 10090 | 20170408 | Impbw1 Bmq3 | Impbw1 imprinted body weight QTL 1 | MGI:MGI:3610975 | 8 | imprinted body weight QTL 1 | unknown O | ||
100036106 | 10090 | 20170408 | Cmn1 | Cmn1 cardiac modifier of nmd 1 | MGI:MGI:3612500 | 9 | cardiac modifier of nmd 1 | unknown O | ||
100036107 | 10090 | 20170408 | Chlq5 | Chlq5 circulating hormone level QTL 5 | MGI:MGI:3613646 | 8 8 43.17 cM | circulating hormone level QTL 5 | unknown O | ||
100036108 | 10090 | 20170408 | Hdlq47 | Hdlq47 HDL QTL 47 | MGI:MGI:3618618 | 18 | HDL QTL 47 | unknown O | ||
100036109 | 10090 | 20170408 | Pgis2 | Pgis2 proteoglycan induced spondylitis 2 | MGI:MGI:3622195 | 2 2 17.24 cM | proteoglycan induced spondylitis 2 | unknown O | ||
100036110 | 10090 | 20211016 | Scgq1 Scg-1 | Scgq1 spontaneous crescentic glomerulonephritis QTL 1 | MGI:MGI:3624655 | 1 1 67.71 cM | spontaneous crescentic glomerulonephritis QTL 1 | unknown O | ||
100036111 | 10090 | 20170408 | Lmr19 | Lmr19 leishmaniasis resistance 19 | MGI:MGI:3625869 | 10 10 45.35 cM | leishmaniasis resistance 19 | unknown O | ||
100036112 | 10090 | 20170408 | Fatpad4 | Fatpad4 fat pad 4 | MGI:MGI:3629112 | 14 | fat pad 4 | unknown O | ||
100036113 | 10090 | 20170408 | Nilac5 | Nilac5 nicotine induced locomotor activity 5 | MGI:MGI:3629973 | 8 8 7.59 cM | nicotine induced locomotor activity 5 | unknown O | ||
100036114 | 10090 | 20211016 | Org1 ORG2.1 | Org1 organ weight 1 | MGI:MGI:3639906 | 2 2 74.83 cM | organ weight 1 | unknown O | ||
100036115 | 10090 | 20211016 | Bod2 BOD4.1 | Bod2 bone length and organs 2 | MGI:MGI:3639910 | 4 4 33.96 cM | bone length and organs 2 | unknown O |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025 |